Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity.

Frasch SC, Fernandez-Boyanapalli RF, Berry KZ, Leslie CC, Bonventre JV, Murphy RC, Henson PM, Bratton DL.

J Biol Chem. 2011 Apr 8;286(14):12108-22. doi: 10.1074/jbc.M110.181800. Epub 2011 Feb 4.

2.

NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A.

Frasch SC, Berry KZ, Fernandez-Boyanapalli R, Jin HS, Leslie C, Henson PM, Murphy RC, Bratton DL.

J Biol Chem. 2008 Nov 28;283(48):33736-49. doi: 10.1074/jbc.M807047200. Epub 2008 Sep 29.

3.

Neutrophils regulate tissue Neutrophilia in inflammation via the oxidant-modified lipid lysophosphatidylserine.

Frasch SC, Fernandez-Boyanapalli RF, Berry KA, Murphy RC, Leslie CC, Nick JA, Henson PM, Bratton DL.

J Biol Chem. 2013 Feb 15;288(7):4583-93. doi: 10.1074/jbc.M112.438507. Epub 2013 Jan 5.

4.

Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling.

Medeiros AI, Serezani CH, Lee SP, Peters-Golden M.

J Exp Med. 2009 Jan 16;206(1):61-8. doi: 10.1084/jem.20082058. Epub 2009 Jan 5.

5.

CD36, but not G2A, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury.

Parks BW, Black LL, Zimmerman KA, Metz AE, Steele C, Murphy-Ullrich JE, Kabarowski JH.

J Lipid Res. 2013 Apr;54(4):1114-23. doi: 10.1194/jlr.M035352. Epub 2013 Feb 6.

6.

Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce redundant signaling through G2A.

Frasch SC, Zemski-Berry K, Murphy RC, Borregaard N, Henson PM, Bratton DL.

J Immunol. 2007 May 15;178(10):6540-8.

7.

Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4.

Fernandez-Boyanapalli RF, Frasch SC, McPhillips K, Vandivier RW, Harry BL, Riches DW, Henson PM, Bratton DL.

Blood. 2009 Feb 26;113(9):2047-55. doi: 10.1182/blood-2008-05-160564. Epub 2008 Oct 24.

8.

Lysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs.

Khan SY, McLaughlin NJ, Kelher MR, Eckels P, Gamboni-Robertson F, Banerjee A, Silliman CC.

Biochem J. 2010 Nov 15;432(1):35-45. doi: 10.1042/BJ20091087.

9.

Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor.

Cherian PP, Cheng B, Gu S, Sprague E, Bonewald LF, Jiang JX.

J Biol Chem. 2003 Oct 31;278(44):43146-56. Epub 2003 Aug 25.

10.

Emerging roles for lysophosphatidylserine in resolution of inflammation.

Frasch SC, Bratton DL.

Prog Lipid Res. 2012 Jul;51(3):199-207. doi: 10.1016/j.plipres.2012.03.001. Epub 2012 Mar 29. Review.

11.

Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner.

Cash JL, Christian AR, Greaves DR.

J Immunol. 2010 May 1;184(9):5315-24. doi: 10.4049/jimmunol.0903378. Epub 2010 Apr 2.

12.

Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype.

Driscoll WS, Vaisar T, Tang J, Wilson CL, Raines EW.

Circ Res. 2013 Jun 21;113(1):52-61. doi: 10.1161/CIRCRESAHA.112.300683. Epub 2013 Apr 12.

13.

High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine.

Liu G, Wang J, Park YJ, Tsuruta Y, Lorne EF, Zhao X, Abraham E.

J Immunol. 2008 Sep 15;181(6):4240-6.

14.

Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia.

Zhang J, Fujii S, Wu Z, Hashioka S, Tanaka Y, Shiratsuchi A, Nakanishi Y, Nakanishi H.

J Neuroimmunol. 2006 Mar;172(1-2):112-20. Epub 2005 Dec 20.

PMID:
16371234
15.

A catalytically-inactive snake venom Lys49 phospholipase A₂ homolog induces expression of cyclooxygenase-2 and production of prostaglandins through selected signaling pathways in macrophages.

Moreira V, de Castro Souto PC, Ramirez Vinolo MA, Lomonte B, María Gutiérrez J, Curi R, Teixeira C.

Eur J Pharmacol. 2013 May 15;708(1-3):68-79. doi: 10.1016/j.ejphar.2013.01.061. Epub 2013 Feb 14.

PMID:
23416211
16.

Induction of caspase- and reactive oxygen species-independent phosphatidylserine externalization in primary human neutrophils: role in macrophage recognition and engulfment.

Jitkaew S, Witasp E, Zhang S, Kagan VE, Fadeel B.

J Leukoc Biol. 2009 Mar;85(3):427-37. doi: 10.1189/jlb.0408232. Epub 2008 Dec 23.

17.

HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin.

Friggeri A, Yang Y, Banerjee S, Park YJ, Liu G, Abraham E.

Am J Physiol Cell Physiol. 2010 Dec;299(6):C1267-76. doi: 10.1152/ajpcell.00152.2010. Epub 2010 Sep 8.

18.

Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.

Tao H, Yancey PG, Babaev VR, Blakemore JL, Zhang Y, Ding L, Fazio S, Linton MF.

J Lipid Res. 2015 Aug;56(8):1449-60. doi: 10.1194/jlr.M056689. Epub 2015 Jun 9.

19.

Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.

Sokolowska M, Chen LY, Liu Y, Martinez-Anton A, Qi HY, Logun C, Alsaaty S, Park YH, Kastner DL, Chae JJ, Shelhamer JH.

J Immunol. 2015 Jun 1;194(11):5472-87. doi: 10.4049/jimmunol.1401343. Epub 2015 Apr 27.

20.

Participation of the receptor for advanced glycation end products in efferocytosis.

Friggeri A, Banerjee S, Biswas S, de Freitas A, Liu G, Bierhaus A, Abraham E.

J Immunol. 2011 Jun 1;186(11):6191-8. doi: 10.4049/jimmunol.1004134. Epub 2011 Apr 18.

Supplemental Content

Support Center